نتائج البحث 381-390 من 14300 لعملية البحث عن Possible thalassaemia trait
This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
[5, 6] An ideal adoptive cellular therapy must possess the ability to not only return to the site of the tumor but must also retain cytotoxic potential after a ...
This information will be available for future research about this spectrum of diseases. Cutaneous Lymphoma Database. Scottsdale/Phoenix, Ariz. The purpose of ...
... potential therapeutic targets. EF-41/KEYNOTE D58: Phase 3 Study Of Optune Concomitant With Temozolomide Plus Pembrolizumab In Newly Diagnosed Glioblastoma.
... available, demographic information, and to develop a biobank of DNA and white blood cell samples from infants with imperforate anus. If patients are ...
The overall goal of this research is to investigate potential differences in the regulation of skin blood flow in individuals with spinal cord injury.
The objective of this study is to evaluate the image quality and radiation dose of a CT angiography protocol (CTA) using tube potential selection and weight- ...
Platelet disorders: Thrombocythemia and thrombocytosis. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/thrombocythemia- ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.